Profiel
Nicole Sweeny is currently Director at Monopar Therapeutics, Inc. since 2026.
Former roles include Vice President-US Marketing at Shire Plc from 2017 to 2019, Vice President-Franchise Head at Takeda Pharmaceuticals U.S.A., Inc. from 2019 to 2020, Chief Commercial Officer at Praxis Precision Medicines, Inc. from 2020 to 2023, and Chief Commercial Officer at KalVista Pharmaceuticals, Inc. Education includes an undergraduate degree from Boston College.
Actieve functies van Nicole Sweeny
| Bedrijven | Functie | Begin |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Directeur/Bestuurslid | 22-06-2026 |
Eerdere bekende functies van Nicole Sweeny
| Bedrijven | Functie | Einde |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Corporate Officer/Principal | 31-03-2023 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01-07-2020 |
| SHIRE | Corporate Officer/Principal | 01-01-2019 |
| KALVISTA PHARMA | Corporate Officer/Principal | - |
Opleiding van Nicole Sweeny
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Monopar Therapeutics, Inc.
Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
















